A recent study in breast cancer cell lines revealed the S-phase kinase-associated protein 2 (Skp2), which is a substrate recognition component of the SC ubiquitin ligase complex, targets ERα but not ERβ for degradation (49). The gene discussed is ESR2; the disease is breast carcinoma.